INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 54 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $52,625 | +31.6% | 250,000 | 0.0% | 0.01% | +22.2% |
Q1 2023 | $40,000 | -71.2% | 250,000 | 0.0% | 0.01% | -70.0% |
Q4 2022 | $138,750 | -53.4% | 250,000 | 0.0% | 0.03% | -51.6% |
Q3 2022 | $298,000 | +88.6% | 250,000 | 0.0% | 0.06% | +87.9% |
Q2 2022 | $158,000 | -44.6% | 250,000 | 0.0% | 0.03% | -35.3% |
Q1 2022 | $285,000 | -49.4% | 250,000 | 0.0% | 0.05% | -42.0% |
Q4 2021 | $563,000 | -34.2% | 250,000 | 0.0% | 0.09% | -36.7% |
Q3 2021 | $855,000 | +14.3% | 250,000 | 0.0% | 0.14% | +23.0% |
Q2 2021 | $748,000 | -53.7% | 250,000 | -50.0% | 0.11% | -18.1% |
Q1 2021 | $1,616,000 | +204.9% | 500,000 | +100.0% | 0.14% | +34.0% |
Q4 2020 | $530,000 | +81.5% | 250,000 | 0.0% | 0.10% | +98.1% |
Q3 2020 | $292,000 | +29.2% | 250,000 | 0.0% | 0.05% | +30.0% |
Q2 2020 | $226,000 | -46.1% | 250,000 | -50.0% | 0.04% | -63.6% |
Q1 2020 | $419,000 | -12.7% | 500,000 | 0.0% | 0.11% | +44.7% |
Q4 2019 | $480,000 | – | 500,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,766,508 | $19,826,000 | 2.39% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,286,032 | $2,610,000 | 0.07% |
Clear Harbor Asset Management, LLC | 153,800 | $312,000 | 0.06% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 219,652 | $445,000 | 0.03% |
Rock Springs Capital Management LP | 270,000 | $548,000 | 0.02% |
Alambic Investment Management, L.P. | 77,665 | $158,000 | 0.02% |
Marshall Wace North America L.P. | 1,173,515 | $2,382,000 | 0.01% |
Baker Brothers Advisors | 580,400 | $1,178,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $932,000 | 0.01% |
Intellectus Partners, LLC | 13,000 | $26,000 | 0.01% |